SCHEMBL5178266

SCHEMBL5178266

CC(C)N(CCC(c1ccccc1)c1cc(N)ccc1O)C(C)C

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM3 P20309 12/20 0.74
CHRM2 P08172 3/20 0.74
CHRM1 P11229 3/20 0.74
HRH1 P35367 3/20 0.74
LMNA P02545 3/20 0.74
MAPT P10636 3/20 0.74
CHRM5 P08912 2/20 0.74
HTR2A P28223 2/20 0.74
ESR1 P03372 1/20 0.74
CHRM4 P08173 1/20 0.74
KCNE1 P15382 1/20 0.74
PTGS1 P23219 1/20 0.74
HRH2 P25021 1/20 0.74
SLC6A4 P31645 1/20 0.74
ADRA1A P35348 1/20 0.74
OPRK1 P41145 1/20 0.74
KCNQ1 P51787 1/20 0.74
KCNH2 Q12809 1/20 0.74
CACNA1C Q13936 1/20 0.74
SCN5A Q14524 1/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6939202 1.00 CHRM3 (0.74) CHRM3CHRM2CHRM1HRH1LMNA
Hydrochloric Acid SCHEMBL5178974 0.99 CHRM3 (0.72) CHRM3CHRM2CHRM1HRH1LMNA
Hydrochloric Acid SCHEMBL27530636 0.99 CHRM3 (0.72) CHRM3CHRM2CHRM1HRH1LMNA
SCHEMBL2473562 0.86 CHRM3 (0.78) CHRM3CHRM2CHRM1HRH1LMNA
SCHEMBL2473559 0.86 CHRM3 (0.78) CHRM3CHRM2CHRM1HRH1LMNA
Tolterodine SCHEMBL29379290 0.85 CHRM3 (1.00) CHRM3CHRM2CHRM1HRH1LMNA
Tolterodine SCHEMBL29635996 0.85 CHRM3 (1.00) CHRM3CHRM2CHRM1HRH1LMNA
Tolterodine SCHEMBL36882 0.85 CHRM3 (1.00) CHRM3CHRM2CHRM1HRH1LMNA
Tolterodine SCHEMBL3064 0.85 CHRM3 (1.00) CHRM3CHRM2CHRM1HRH1LMNA
Tolterodine SCHEMBL580446 0.85 CHRM3 (1.00) CHRM3CHRM2CHRM1HRH1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100482635-C Noval compounds, their use and preparation PFIZER HEALTH AB (SE) 2009-04-29 CN claimed
EP-1019358-B2 3,3-DIARYLPROPYLAMINES , THEIR USE AND PREPARATION PFIZER HEALTH AB (SE) 2007-09-12 EP claimed
CN-1636967-A Noval compounds, their use and preparation PFIZER (SE) 2005-07-13 CN claimed
EP-1019358-B1 3,3-DIARYLPROPYLAMINES , THEIR USE AND PREPARATION PHARMACIA AB (SE) 2003-05-07 EP claimed
US-6313132-B1 FOR THERAPY OF URINARY INCONTINENCE, ACETYLCHOLINE-MEDIATED DISORDER PHARMACIA AB (SE) 2001-11-06 US claimed
EP-1019358-A1 NOVEL COMPOUNDS, THEIR USE AND PREPARATION Pharmacia & Upjohn AB (SE) 2000-07-19 EP claimed
CN-1251569-A Novel compounds, their use and process for their preparation PHARMACIA & UPJOHN AB (SE) 2000-04-26 CN claimed
WO-1998043942-A1 NOVEL COMPOUNDS, THEIR USE AND PREPARATION PHARMACIA & UPJOHN AB (SE) 1998-10-08 WO claimed
CN-100482635-C Noval compounds, their use and preparation PFIZER HEALTH AB (SE) 2009-04-29 CN disclosed
EP-1019358-B2 3,3-DIARYLPROPYLAMINES , THEIR USE AND PREPARATION PFIZER HEALTH AB (SE) 2007-09-12 EP disclosed
CN-1636967-A Noval compounds, their use and preparation PFIZER (SE) 2005-07-13 CN disclosed
EP-1019358-B1 3,3-DIARYLPROPYLAMINES , THEIR USE AND PREPARATION PHARMACIA AB (SE) 2003-05-07 EP disclosed
US-6313132-B1 FOR THERAPY OF URINARY INCONTINENCE, ACETYLCHOLINE-MEDIATED DISORDER PHARMACIA AB (SE) 2001-11-06 US disclosed
EP-1019358-A1 NOVEL COMPOUNDS, THEIR USE AND PREPARATION Pharmacia & Upjohn AB (SE) 2000-07-19 EP disclosed
CN-1251569-A Novel compounds, their use and process for their preparation PHARMACIA & UPJOHN AB (SE) 2000-04-26 CN disclosed
WO-1998043942-A1 NOVEL COMPOUNDS, THEIR USE AND PREPARATION PHARMACIA & UPJOHN AB (SE) 1998-10-08 WO disclosed